Content Topics

Climate 77

View All

Deep Tech Opportunities Report

Deep Tech Opportunity: Water offsets are giving big water users a responsible way to keep growing

Deep Tech Opportunities Report

DCVC DTOR 2025: One overlooked source of clean water is polluted water

Deep Tech Opportunities Report

DCVC DTOR 2025: For the environment and for our health, we must learn to produce more food, more efficiently

Deep Tech Opportunities Report

DCVC DTOR 2025: Innovators are finding better ways to lean on nature to remove carbon from the atmosphere

Computational Bio & Chem 29

View All

Deep Tech Opportunities Report

Deep Tech Opportunity: Third-generation gene therapy companies are advancing toward cures for major diseases that can be treated in no other way

Company Profile

Built to break barriers: How Grove Biopharma is architecting its way around traditional drug limits

By Dr. Emily Park, Dr. Kiersten Stead

Latus Bio finds a better way to deliver genes to cells deep in the brain to help patients with neurodegeneration

By Dr. Kiersten Stead

Creyon Bio deal with Lilly brings up to $1 billion in payments for research on RNA-targeting drugs

By Dr. Kiersten Stead

Cybersecurity, Security, & Defense 17

View All

How Fortem is helping the U.S. and its allies get ahead of the drone threat

By Matthew Ocko, Matt O'Connell

Human identity needs a Zero Trust moment

Reality Defender democratizes deepfake detection with public API launch

Reality Defender answers FINRA call

Enterprise Enablement 5

View All

Davos 2024: A decisive moment for DCVC’s deep tech investment thesis

By Zachary Bogue

DCVC companies are at the forefront of better generative AI: Databricks to acquire MosaicML for $1.3B

By Matthew Ocko

Element AI raises $151M Series B to enable artificial intelligence at the heart of every company

By Matthew Ocko, Zachary Bogue

DCVC Portfolio IPO: Elastic goes public, opening at a $4.4 billion valuation

By Matthew Ocko, Zachary Bogue

Finance & Insurance 4

View All

A new precision power market

DCVC proud to back ElectronX in its quest to build the first-ever direct-access regulated derivatives exchange for the electric power markets

Deep Tech Opportunities Report

Cryptography for the real world

StarkWare Raises $30M Series A to Build Post-Quantum Secure Blockchain

By Matthew Ocko

Foundational Technology 13

View All

A new pinnacle in fault tolerant quantum computing

By Dr. Prineha Narang

Quantum’s super position

By Matthew Ocko, James Hardiman, Dr. Prineha Narang

Mythic raises $125M to break through AI’s power wall

By Matthew Ocko

Deep Tech Opportunities Report

DCVC DTOR 2025: America needs exponentially greater computing power, in more locations, using less electricity

Industrial Transformation 34

View All

Deep Tech Opportunities Report

DCVC DTOR 2025: One overlooked source of clean water is polluted water

Deep Tech Opportunities Report

DCVC DTOR 2025: Robots should be backward-compatible with the real world

Fulfil’s robot revolution comes to Whole Foods

Company Profile

Flexible Power for an inflexible grid: Why DCVC backed Mainspring Energy

Smart Agriculture 17

View All

Deep Tech Opportunities Report

DCVC DTOR 2025: For the environment and for our health, we must learn to produce more food, more efficiently

Halter’s invisible fencing drives an inevitable shift in ranching

By Spencer Punter

Company Profile

Elo’s breakthrough science offers scalable, domestic solutions to replacing sugar and artificial sweeteners

By Dr. Justin Kern

Deep Tech Opportunities Report

DCVC DTOR 2024: Drop-in replacements are a way to start decarbonizing the economy, now

Space 9

View All

DCVC anchors $150 million in financing for Impulse Space to deliver precise, fast, and affordable maneuverability of satellites within and between orbits

By Matthew Ocko, Matt O'Connell

Davos 2024: A decisive moment for DCVC’s deep tech investment thesis

By Zachary Bogue

DCVC Announcements

DCVC Welcomes 2022

On Going to Space

TechBio 10

View All

Deep Tech Opportunities Report

Deep Tech Opportunity: TechBio companies are using data to rethink how we develop new medical treatments

Proxima raises $80M in seed financing, led by DCVC, to reprogram protein-protein interactions

By Jason Pontin

Noetik’s partnership with GSK puts dollar signs on the AI licensing business model in TechBio

By James Hardiman

Company Profile

Why Kanvas built its own production line for microbiome therapeutics

By Jason Pontin

TechMed 22

View All

Valar’s AI-derived biomarker is a game-changer for treating pancreatic cancer

By James Hardiman

Remedy’s AI-powered robot supports world’s first remote neurointervention

By James Hardiman

Proprio’s latest FDA approval clears the way for better, AI-driven surgery

Proprio's Physical AI at the 2025 JPM Healthcare Conference